Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIDEL: Early Fibrinogen for Post-Partum Hemorrhage
NCT02155725Phase 4Completed
- Sponsor
- LFB Group
- Start
- Apr 2014
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Human Fibrinogen concentrate with Placebo (2 arms). Primary endpoint: Failure Rate of PPH Management at 48 hours. Started Apr 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02155725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02155725.